To assess the current status and future perspectives of minimal-invasive nephron-sparing surgery (NSS) including extirpative and ablative techniques. Minimally invasive nephron-sparing surgery for renal tumors comprises extirpative laparoscopic partial nephrectomy (LPN) and ablative procedures such as cryoablation, radiofrequency ablation, as well as radiosurgery. Minimally invasive nephron-sparing surgery modalities offer reduced morbidity as compared with open partial nephrectomy. Recent trials comparing laparoscopic partial nephrectomy and open partial nephrectomy demonstrated equivalent cancer-specific survival. Encouraging long-term data are becoming increasingly available for laparoscopic partial nephrectomy and cryoablation. However, some concerns remain about incomplete tumor cell kill after radiofrequency ablation. Radiosurgery is a promising new technology, but is still experimental. The increasing availability of robotic assistance in urologic oncology also allows for novel therapeutic concepts such as single-port laparoscopy. Open and laparoscopic partial nephrectomies are the standard-of-care for treating small renal masses, with LPN becoming the preferred option in high-volume urooncology centers. Continuing research adds to the value of ablative technologies.
机构:
Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY 10467, 34 Bainbridge AvenueAlbert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY 10467, 34 Bainbridge Avenue
Ghavamian R.
Zincke H.
论文数: 0引用数: 0
h-index: 0
机构:
Department of Urology, Mayo Clinic, Rochester, MN 55905Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY 10467, 34 Bainbridge Avenue